Literature DB >> 23298873

Preferences for death and dying among veterans with chronic obstructive pulmonary disease.

Lynn F Reinke1, Jane Uman, Edmunds M Udris, Brianna R Moss, David H Au.   

Abstract

RATIONALE: Studies identify common factors important for a "good death." However, it is important for clinicians to individualize end-of-life care by eliciting patients' preferences. We sought to determine preferences for death and dying among veterans with chronic obstructive pulmonary disease (COPD) by performing a cross-sectional study. Participants (n = 376) completed a preferences about death and dying questionnaire.
RESULTS: Common themes ranked as most important by veterans include health care costs (86.6%) and avoiding strain on loved ones (78.8%). Unique items include being unafraid of dying (67.1%) and having discussed your treatment preferences with your clinician (59.3%).
CONCLUSION: Preferences for death and dying are consistent among individuals with life-limiting illness, thus should be incorporated as core components in all end-of-life care planning. We identified unique preferences important to patients with COPD. This study suggests that clinicians need to engage in end-of-life discussions to learn about individual preferences to improve the patients' dying experience.

Entities:  

Keywords:  chronic obstructive pulmonary disease; death and dying; end-of-life communication; patient preferences

Mesh:

Year:  2013        PMID: 23298873     DOI: 10.1177/1049909112471579

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

Review 1.  Defining a Good Death (Successful Dying): Literature Review and a Call for Research and Public Dialogue.

Authors:  Emily A Meier; Jarred V Gallegos; Lori P Montross Thomas; Colin A Depp; Scott A Irwin; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-01-22       Impact factor: 4.105

Review 2.  Masculinity and Military Culture in VA Hospice and Palliative Care: A Narrative Review With Clinical Recommendations.

Authors:  Evan Plys; Ronald Smith; M Lindsey Jacobs
Journal:  J Palliat Care       Date:  2019-05-30       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.